Deepflare is a startup. Brouky records 1 investor associated with the company.
Deepflare predicts true T-cell immunogenicity with 12x greater accuracy than standard tools. Design next-generation antigen candidates for vaccines and immunotherapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.